2007-January Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Tue Jan 2 10:34:01 2007
Ending: Wed Jan 31 20:15:02 2007
Messages: 116

• [Ip-health] arstechnica: economics of pharmaceuticals and IP   Manon Ress
• [Ip-health] Symposium: Effects of Intellectual Property Protections on Scientific Research   Michael Kisielewski
• [Ip-health] Scientists find way to slash cost of drugs   Ira Glazer
• [Ip-health] Guardian: Scientists on a mission to bring cheap drugs to the world's poorest countries   Gavin Baker
• [Ip-health] New report now available: NGOs, Intellectual Property Rights and Multilateral Institutions   Duncan Matthews
• [Ip-health] CS Monitor: India drug firms move from serving poor to competing for rich   Alex Sugerman-Brozan
• [Ip-health] EU-US trade ties high on German presidency agenda - incl Patents   Riaz K Tayob
• [Ip-health] Boston Globe: Drug costs imperil Brazil AIDS fight   Mike Palmedo
• [Ip-health] Guardian: Big Pharma's Bad Karma   Mike Palmedo
• [Ip-health] WSJ: Inside Abbott's Tactics to Protect AIDS Drug   robert weissman
• [Ip-health] WSJ: Abbott Laboratories' Norvir Plan - Internal Memo   robert weissman
• [Ip-health] Royalties on Sale of Products Licensed under Bayh-Dole to Government Agencies   James Love
• [Ip-health] New tool watches DC's (including USTR) "revolving door;"   robert weissman
• [Ip-health] Lancet editorial on Novartis in India and Thailand compulsory license   Ellen T HOEN
• [Ip-health] Monsanto men "holding the strings to the Gates Foundation's large purse"   Riaz K Tayob
• [Ip-health] IHT: At WHO, a chief cut from Hong Kong cloth   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Los Angeles Times: Dark cloud over good works of Gates Foundation   Thiru Balasubramaniam
• [Ip-health] OMB asked to use US rights in government funded patents to buy two generic AIDS drugs (d4T and ritonavir)   James Love
• [Ip-health] Dark Cloud Over Good Works of Gates Foundation (mea culpa?)   Riaz K Tayob
• [Ip-health] new Deputy-Director General for the World Health Organization   Michelle Childs
• [Ip-health] Please sign our malaria control funding request letter   Philip Coticelli
• [Ip-health] Supreme Court in MedImmune case   Benjamin Krohmal
• [Ip-health] USTR puts Chile on Priority Watch list - citing pharma issues   robert weissman
• [Ip-health] Global health organization prepares to name leader   Riaz K Tayob
• [Ip-health] IP-Watch: People News - Steiger To Africa, Sigall To Microsoft   Thiru Balasubramaniam
• [Ip-health] US and India Sign Historic MoU on Bilateral Cooperation on IP   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] Malaysia-US FTA negotiations hit turbulence (Aliran)   Sangeeta
• [Ip-health] IP-Watch Inside Views: Interview With Howard Zucker, Senior WHO Official On IP   Thiru Balasubramaniam
• [Ip-health] U Washington announces socially responsible IP management   Amy Kapczynski
• [Ip-health] Hooked on Drug Money: Will Congress Take a Stand on Medicare?   Riaz K Tayob
• [Ip-health] Vietnam joins today the WTO   Judit Rius Sanjuan
• [Ip-health] Washington Post: Drug Bill Demonstrates Lobby's Pull Democrats Feared Industry Would Stall Bigger Changes   Thiru Balasubramaniam
• [Ip-health] 22 Members of Congress urge USTR to respect Thai CL for efavirenz   ben.krohmal@cptech.org
• [Ip-health] Nature story on Novartis case   Malini Aisola
• [Ip-health] New Congress Can Save Lives, or Money   Riaz K Tayob
• [Ip-health] RE: MASHELKAR REPORT   charlesclift@tiscali.co.uk
• [Ip-health] Philips seeks WTO help in Taiwan compulsory licensing dispute   robert weissman
• [Ip-health] Press Coverage on Mashelkar Committee in India   Gopa Kumar
• [Ip-health] EU urged to support India in drug-patent battle   Alexandra HEUMBER
• Fwd: [Ip-health] RE: MASHELKAR REPORT   Luis Nogues
• [Ip-health] Right version : "EU urged to support India in drug-patent battle"   Alexandra HEUMBER
• [Ip-health] Job Announcement: Essential Action's Pharma Transparency and Monitoring Project   robert weissman
• [Ip-health] TB Experts Outline Proposals to Speed Up Drug Development   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Comments on Mashelkar Committee   Gopa Kumar
• [Ip-health] Parallel Importation Bill and the US-Australia FTA   Mike Palmedo
• [Ip-health] China says int'l (WTO) IP rules will apply in domestic trials   Riaz K Tayob
• [Ip-health] Revised article: Calls for fast access to sleeping sickness drug   Ann-Marie Sevcsik
• [Ip-health] Parallel import controversy in Kenya   Mike Palmedo
• [Ip-health] Parallel Importation Bill and the US-Australia FTA   Kevin Outterson
• [Ip-health] USTR Criticizes Chile On IPR   Stephanie Burgos
• [Ip-health] Members of the WHO Executive Board for January 2007 meeting   Thiru Balasubramaniam
• [Ip-health] Kenya Switzerland draft document for WHO EB: Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action-Areas for early implementation   thiru@cptech.org
• [Ip-health] Clarification on Kenya/Switzerland document   thiru@cptech.org
• [Ip-health] Original text of Kenya/Switzerland draft resolution on "Areas for early implementation"   thiru@cptech.org
• [Ip-health] news coverage of Congressional letter to USTR on Thailand CL   Benjamin Krohmal
• [Ip-health] Invitation: Hearing at European Parliament "PATIENTS BEFORE PATENTS"   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] AFL-CIO against TRIPS+ in US-Malaysia FTA   Mike Palmedo
• [Ip-health] IPR a hard sell in Malaysia   Chee Yoke Ling
• [Ip-health] 16 NY labor leaders' letter to Rep. Rangel including opposition to TRIPS+ in FTAs   Mike Palmedo
• [Ip-health] Re: Ip-health digest, Vol 1 #2239 - 8 msgs   Gopa Kumar
• [Ip-health] Re: [HEALTHGAP] Chairman Rangel Announces a Hearing on Trade and Globalization   Judit Rius Sanjuan
• [Ip-health] Vacancies at South Centre-Head Programmes and Research Coordination and Head Communications   musungu@southcentre.org
• [Ip-health] Thailand plans 3 More Compulsory Licenses   robert weissman
• [Ip-health] Thailand issues more compulsory drugs licences / Reuters / 25.01.07   James Love
• [Ip-health] Journal publishers lock horns with free-information movement   Tim Hubbard
• [Ip-health] KEI Statement on Thailand Compulsory licenses   James Love
• [Ip-health] more coverage of new Thai CL's   Benjamin Krohmal
• [Ip-health] Huffington Post on Thai CLs   Benjamin Krohmal
• [Ip-health] MSF Media Alert: Novartis case- Press Teleconference Friday January 26 10 am EST   Buddhima Lokuge
• [Ip-health] BMJ on Novartis vs India: MSF challenges Novartis's action over Indian patent for imatinib   thiru@cptech.org
• [Ip-health] [ICTSD Report] US FTA NEGOTIATIONS WITH KOREA, MALAYSIA STRUGGLING   heeseob nam
• [Ip-health] British Medical Journal on Novartis vs India- Quote on the EP Hearing 23rd January   Alexandra HEUMBER
• [Ip-health] Why Nonprofits Fund For-Profit Companies Doing Drug Research   James Love
• [Ip-health] FromGeneva: WHO Executive Board discusses Public Health, Innovation, and Intellectual Property (IGWG)   thiru@cptech.org
• [Ip-health] PhRMA lies and distortions - Thai compulsory licenses   B.Baker@neu.edu
• [Ip-health] Novartis' Challenge to India's Patent Act, section 3d   B.Baker@neu.edu
• [Ip-health] WHO executive board TRIPS language dispute   Benjamin Krohmal
• [Ip-health] US-Panama TPA: draft text public   Judit Rius Sanjuan
• [Ip-health] Mashelkar Report Misstates India's Right to Define Scope of Patentability   B.Baker@neu.edu
• [Ip-health] Defamation Notice from CPAA to Daniel Vasella   chan park
• [Ip-health] Update on Novartis Hearing, 29.1.07   chan park
• [Ip-health] Update on Novartis Hearing in Madras High Court   chan park
• [Ip-health] WHO flu chief leaves for Novartis   Joana Ramos
• [Ip-health] Word (World) to Novartis: drop lawsuit over Indian patent law   James Love
• [Ip-health] MSF: Nearly a Quarter of a Million people Urge Novartis to Drop its Court Case in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Will the real Mashelkar stand up?   Achal Prabhala
• [Ip-health] url for Mashelkar Critique   B.Baker@neu.edu
• [Ip-health] FT: Letter from MSF&Oxfam : What could be more of a short-term fix than the Novartis programme?   Alexandra HEUMBER
• [Ip-health] Support Public Access to Medical Research   Benjamin Krohmal
• [Ip-health] Worldwide call for open access to European research   Judit Rius Sanjuan
• [Ip-health] IHT /NYTimes: Drugs for poor and patent rights at issue in Novartis suit in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] AP: Hundreds protest Swiss pharmaceutical giant's challenge to Indian patent law   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Reuters: Swiss drug case threatens developing world: MSF   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Marketplace: Protests target drug company's patent fight   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Op-ed on Canada's Access to Medicines Regime   Laura Esmail
• [Ip-health] "Third Global Congress Combating Counterfeiting and Piracy"   Thiru Balasubramaniam
• [Ip-health] Worldmapper: Royalty Fees   Thiru Balasubramaniam
• [Ip-health] SUNS: WHO: Executive Board unable to reinvigorate IP Group process   Thiru Balasubramaniam
• [Ip-health] IP-Watch: NGOs, Industry Differ On WHO IP, Innovation, Public Health Project   Thiru Balasubramaniam
• [Ip-health] Novartis Funded Max Foundation Supports...Novartis   Benjamin Krohmal
• [Ip-health] TRIPS+ threaten fivefold increase in PEPFAR costs   Benjamin Krohmal
• [Ip-health] Thai CL for clopidogrel patents (in English)   James Love
• [Ip-health] Thai CL for Kaletra patents (English)   James Love
• [Ip-health] Re: [A2k] Worldmapper: Royalty Fees   john@creativeeconomy
• [Ip-health] HEALTH-INDIA: Anger Grows at Novartis' Bid to Hog Cancer Drug   chan park
• [Ip-health] PTI: CPAA sends defamation notice to Novartis   chan park
• [Ip-health] PTI: CPAA sends defamation notice to Novartis   Mira Shiva
• [Ip-health] Wall Street Journal: Thai Move to Trim Drug Costs Highlights Growing Patent Rift   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Industry, Intergovernmental Organizations Launch Global Anti-Piracy Blitz   Thiru Balasubramaniam
• [Ip-health] Financial Times: Thailand confirms switch to generic medicines   Thiru Balasubramaniam
• [Ip-health] Re: [A2k] Will the real Mashelkar stand up?   Rishab Aiyer Ghosh
• [Ip-health] Bridges Weekly Trade News Digest: Thailand Authorises Generic Production of Two More Patented Drugs   Thiru Balasubramaniam
• [Ip-health] Clarifications on Thai Compulsory Licensing   robert weissman
• [Ip-health] USTR response to Congressional Thailand letter   Benjamin Krohmal
• [Ip-health] WIPO gives Thai King first global leaders award   James Packard Love
• [Ip-health] Tom Giovanetti on the Thailand King and compulsory licensing   James Love

Last message date: Wed Jan 31 20:15:02 2007
Archived on: Wed Jan 31 20:15:03 2007

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...